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ABSTRACT 
Blood bilirubin level would be elevated when one’s liver is unable to remove bilirubin 
sufficiently from the blood. The conventional methods used for monitoring and 
measuring the bilirubin level are time consuming, tedious and invasive in nature.  This 
study aims to investigate the feasibility of using Modified Lambert Beer (MLB) A 
model in the prediction of one’s bilirubin concentration using a priori knowledge of 
the extinction coefficient of bilirubin and haemoglobin components in the wavelength 
range of 400–500 nm. This study verified validity of the predicted value using light 
attenuation data from TracePro for a single-layered skin model with varying bilirubin 
concentration. The results revealed some promising trends in estimated bilirubin 
concentration and considerably good accuracy with percent mean relative error in the 
predicted bilirubin concentration, Cbil(p) calculated as 59.9 %. This study performed 
contact and non-contact experiments for the demonstration works. A total number of 
60 individuals of different health status, skin tone and gender have been recruited for 
the contact experiment. Meanwhile, six healthy subjects was recruited for the non-
contact experiment, and measurement was performed at various selected skin sites. 
From the contact experiment, this work found a lower skin bilirubin level in renal 
disease subjects compared to healthy subjects. In addition, a lower bilirubin was 
observed for individuals with dark skin compared to fair skin, and a higher bilirubin 
level in male compared to their female counterparts. Based on the experiments 
performed on healthy subjects using non-contact experiment arrangement, this work 
found that palm site has the lowest in the predicted mean transcutaneous bilirubin 
concentration with highest consistency given by 0.44±0.4 g/l as compared to other skin 
sites. This study concluded that the developed system and strategy may be used as an 
alternative means to assess one’s skin bilirubin level. 
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ABSTRAK 
Tahap bilirubin darah akan meningkat apabila organ hati seseorang tidak dapat 
menyingkirkan bilirubin secukupnya dari darah. Kaedah konvensional yang digunakan 
untuk memantau dan mengukur tahap bilirubin memakan masa, membosankan dan 
bersifat invasif. Kajian ini bertujuan menggunakan model Modified Lambert Beer 
(MLB) A dalam meramalkan kepekatan bilirubin seseorang dengan menggunakan 
pengetahuan awal mengenai pekali kewujudan bilirubin dan hemoglobin dalam julat 
gelombang 400-500 nm. Kajian ini mengesahkan kesahihan nilai yang diramalkan 
menggunakan attenuation data dari TracePro untuk model kulit satu lapisan dengan 
kepekatan bilirubin yang berbeza. Keputusan menunjukkan beberapa trend yang 
menjanjikan harapan tinggi dalam kepekatan bilirubin yang dianggarkan dan ketepatan 
yang sangat baik dengan peratus ralat min purata ramalan bilirubin yang diramalkan, 
Cbil(p) dikira sebagai 59.9 %. Kajian itu melakukan eksperimen bersentuhan dan tidak 
bersentuhan, untuk eksperimen bersentuhan dilakukan pada 60 subjek manusia dengan 
status kesihatan yang berbeza, ton kulit dan jantina. Sementara itu, eksperimen tidak 
bersentuhan dilakukan pada enam subjek yang sihat di pelbagai bahagian kulit yang 
berbeza. Kerja ini mendapati tahap bilirubin kulit yang lebih rendah dalam subjek 
penyakit buah pinggang berbanding dengan subjek yang sihat. Di samping itu, 
bilirubin yang rendah dalam subjek kulit gelap berbanding subjek kulit cerah dan 
bilirubin yang tinggi pada lelaki berbanding rakan perempuan mereka. Berdasarkan 
eksperimen yang dijalankan ke atas subjek yang sihat menggunakan perkiraan 
eksperimen bukan hubungan didapati bahawa tapak tangan mempunyai kadar terendah 
dalam ramalan bilirubin transkutan dengan nilai konsistensi tertinggi iaitu 0.44±0.4 g/l 
berbanding dengan tapak kulit yang lain. Kajian ini menyimpulkan bahawa sistem dan 
strategi yang dibangunkan boleh digunakan sebagai cara alternatif untuk menilai tahap 
bilirubin kulit seseorang. 
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CHAPTER 1 
INTRODUCTION 
This chapter is structured as follows: in Section 1.1, a background study of the human 
body structure is briefly explained. The problem statements that motivated the current 
research work are discussed in Section 1.2. The objectives of this research are 
mentioned in Section 1.3, followed by the list of the scopes in Section 1.4. 
1.1 Background of study 
Human body is a combination of different complex organs. All these organs have their 
own function for daily operation in human body. The bone marrow is bone structures 
having the purpose of producing red blood cells. Red blood cells contain protein of 
haemoglobin to transport the oxygen throughout human body[1]. These red blood cells 
have their own life span, and old red blood cells which have reduced abilities to carry 
oxygen should be removed from the body. The elevation in blood bilirubin level will 
occur when old red blood cells are unable to be removed from the body. Apparently, 
neonates will have a higher probability of bilirubin elevation than adults, this is due to 
the fact their red blood cells have a shorter life span. This condition is known as 
neonatal jaundice or neonatal hyperbilirubinemia[2-4]. Liver is the main organ that 
helps human body to filter out all the unwanted waste and discharge from the system, 
and this includes bilirubin produced from the breakdown of old red blood cells[5, 6]. 
When the liver is unable to function correctly it will result in an increase level of 
bilirubin circulating in the blood stream. Yellowish sclera shown in Figure 1.1 and 
skin (Jaundice) are normally used by healthcare professionals as clues to the build-up 
of blood bilirubin level. Besides that, the pale appearance of the skin, discharge of dark 
urine and chalky stools have also been used as clues of neonates suffer from neonatal 
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jaundice. Jaundice commonly appears in the first 24 hours upon birth. If this situation 
lasted for 14 days it is diagnosed as prolonged jaundice. This diagnosis is often 
accompanied and confirmed via other clinical tests. Sick neonates with high 
concentrations bilirubin displacing metabolites, and premature neonates that have 
impaired blood-brain barrier are prone to severe hyperbilirubinemia, which in turn can 
cause permanent brain damage (kernicterus). Kernicterus will cause devastating 
disabilities, such as hearing impairment, athetoid cerebral palsy and speech. Some of 
the neonates with kernicterus ended up intelligent, however, they are unable to control 
their body abilities[7]. Jaundice in adults is normally caused by renal failure, liver 
disease (hepatitis), and blockage of bile ducts[8]. The high level of bilirubin in one’s 
blood circulation system may result in fatigue, nausea and abdominal pain, and in some 
severe cases it may lead to kernicterus [3, 4].  
 
Figure 1.1: Yellowish sclera[9] 
For years, the development of a reliable optical system to identify level of 
bilirubin in human body is becoming crucial[10]. This is owing to the fact that a system 
that is non-invasive in nature, which offers painless, safe procedures and does not 
require the drawing of blood sample or urine sample for laboratory test in the 
monitoring of a patient’s condition, is often desirable. In addition, the system will have 
to be real time and user friendly for ease of use by the clinical staff.  This would overall 
reduce stress amongst patients and neonates’ parents with the short waiting time in its 
diagnosis.  
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1.2 Problem statement 
To date, all the hospital services are still using the conventional method to determine 
one’s bilirubin level. These conventional clinical methods are either through the 
drawing of blood sample (phlebotomy technique), urine sample or via observation of 
clotting of plasma[8]. These methods are time consuming and may lead to several 
drawbacks such as unnecessary blood loss, an increased risk of osteomyelitis 
(inflammation of bone) shown in Figure 1.2 and infection at the sampling site[8, 11-
13].  
 
Figure 1.2: Osteomyelitis[14] 
The infeasibility to perform real time measurement of one’s bilirubin level is 
because of the operating principle and technology of the equipment involved. For 
example, withdrawal of blood sample from a patient is needed in determining one’s 
bilirubin level using blood gas analyser. In addition to the time taken to draw the blood, 
a certain time duration is also required to analyse the data using the corresponding 
equipment. The blood drawing process can be painful to the patients, especially for the 
newborns. In the cases of newborns diagnosed with jaundice, the constant drawing of 
blood sample is required until their bilirubin level has returned to normal. This whole 
process is likely to cause anxiety to the parents. It must be mentioned that there are 
several types of non-invasive devices available in the market that are able to determine 
one’s skin bilirubin. However, none of these non-invasive devices manage to replace 
the above mentioned traditional methods. These devices are not reliable and lack of 
accuracy due to differences in the patients’ skin colour. Hence, the devices are deemed 
unsuitable to be used on individuals with dark skin.  
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1.3 Objectives 
This research is conducted to achieve the following objectives: 
i. To develop a real time optical system for non-invasive monitoring of bilirubin 
level in jaundiced patients and healthy persons. 
ii. To determine and evaluate the performance of the developed light attenuation 
models used for quantification of transcutaneous bilirubin level. 
iii. To investigate the variation in the transcutaneous bilirubin level across 
different skin region for the proposal of the optimal skin site measurement. 
1.4 Scope 
The scopes of this study are: 
i. To employ an optical system consisting of a wideband light source, diffraction 
grating element and mirrors for detection of light reflected from the selected 
skin sites. Real time data acquisition is via a source code written in MATLAB. 
ii. To develop different attenuation models in the estimation of transcutaneous 
bilirubin level using MATLAB. The performance of these models is evaluated 
via simulation data from TracePro software.  
iii. To tabulate and compare transcutaneous bilirubin level collected from this 
study using a non-contact optical technique on skin sites of different 
individuals namely thenar region of the palm, back of the hand, posterior 
forearm and anterior forearm. 
iv. To tabulate and compare transcutaneous bilirubin level collected using contact 
optical technique on individuals of different health status, skin tone and gender 
from the back of their hand. 
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CHAPTER 2 
LITERATURE REVIEW 
This chapter provides an overview of literature review related to this project. Section 
2.1 to Section 2.3 are the human skin structure with the component underneath the skin. 
A review of previous works involving the measurement of bilirubin in Section 2.4, 
followed by the available software of simulating the light propagation in skin in 
Section 2.5. Section 2.6 describes the use of available light attenuation model for 
measurement of component underneath skin. 
2.1 Human skin structure  
Human skin is inhomogeneous structure divided into three main layers namely 
epidermis, dermis and subcutaneous tissue[1]. Figure 2.1 shows the cross sectional of 
human skin layer. The epidermis layer is the outer part, thinner layer that covered the 
dermis layer. Epidermis consists of two layers: living cell and non-living cell. It is also 
known as blood free layer; therefore, it receives the nutrients from the dermis layer. 
Dermis is known as the blood-rich layer and lies sheltered under the epidermis. The 
connective tissues are present in this layer, where it consists of elastic fibres and 
collagen fibres. Besides, the numerous of sensory nerve is also present in this layer. 
Meanwhile, subcutaneous tissues are the thickest among these three tissues; it contains 
fats to absorb nutrients and provide energy. These three layers have different thickness 
depending on individual.  
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Figure 2.1: The human skin structure[1] 
The knowledge of skin structure and properties is important in understanding 
the operating principle of most non-invasive techniques. The optical properties in each 
particular layer are different. Each layer has different thickness and structure. The skin 
modeling previously used in Monte Carlo simulation was divided into seven layers as 
presented by Meglinski and Matcher[15]. In epidermis layer, it was divided into two 
layers namely stratum corneum and living epidermis, whereas dermis layer was 
divided into four layers: papillary dermis, upper blood net dermis, reticular dermis and 
deep blood net dermis. The deepest layer was subcutaneous tissues. These seven layers 
have been considered in their study of light penetration into the skin. The thickness of 
each skin layer is presented in Table 2.1. 
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Table 2.1: Seven-layer skin model of different thickness used in the work of Meglinski 
and Matcher[15] 
Skin layer Thickness (µm) 
Stratum corneum 
Living epidermis 
Papillary dermis 
Upper blood net dermis 
Reticular dermis 
Deep blood net dermis 
Subcutaneous tissues 
20 
80 
150 
80 
1500 
100 
6000 
 
Meanwhile, Zhang et al[16] reported the high computational time in skin 
modelling using Monte Carlo simulation. The workers have, therefore, proposed the 
use of genetic algorithms to simplify the seven skin layers into three[15]. The 
epidermis, papillary upper dermis and reticular dermis are the three layers that were 
taken into consideration in the skin modelling. In the corresponding study, melanin 
was the main absorbance in the epidermis[15]. However, due the fact that absorption 
of melanin is dominant only at shorter wavelengths in the wavelength ranged from 250 
nm to 1,200 nm, the presence of melanin was considered negligible. Figure 2.2 shows 
optical pathways into skin and the process of light penetration into human skin. For 
light photons that incident on stratum corneum approximately 5 % of the light would 
be reflected while others would penetrate into skin. This is owing to the fact that 
stratum corneum is uneven and planar. In epidermis layer, the inhomogeneities 
scattering happened and this results in epidermal remittance. Light impinged on the 
skin would penetrate through epidermis before reaching the dermis layer. Visible light 
of wavelengths in the range of 450 nm to 600 nm could penetrate up to a depth of 500 
nm within the dermis layer. 
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Figure 2.2:Optical pathway into human skin layers[17] 
2.2 Different component underneath the skin 
The main absorber in epidermis layer is known as melanin[18]. Melanin’s 
absorption changes linearly with the wavelength. Therefore, the present of the melanin 
is rarely taken into consideration. The wavelength dependent absorption of melanin 
can be expressed as follows[15]: 
9 3.335 10mel 
−=       (mm-1)                                           (2.1) 
Meanwhile, deoxyhaemoglobin, oxyhaemoglobin and bilirubin are the main 
component of medium absorbers available in the dermis layer. It must also be 
mentioned that deoxyhaemoglobin (Hb) and oxyhaemoglobin (HbO2) are the 
parameter that mostly affect the reading of the bilirubin. This is due to the strong 
absorptivity of haemoglobin chromophores at the peak of bilirubin absorption at 
wavelength of approximately 450 nm as shown in Figure 2.3. The blood absorption 
dependent in blood oxygen saturation is expressed as followed[19]: 
PTTA
PER
PUS
TAK
AAN
 TU
NKU
 TU
N A
MIN
AH
9 
 
( )
2 2
[ ]blood HbO Hb HbSO T   = −  +                                        (2.2) 
where SO2 is blood oxygen saturation (%) and T is total blood concentration and is 
given by 150 g Hb/liter[19]. Meanwhile, εHbO2 and εHb is molar extinction coefficient 
of HbO2 and Hb, respectively. 
The µblood in Equation 2.2 can be converted into light absorbance, a via the 
following equation[19]: 
2.303
( )blood
Hb
T
a
W
  
=                                             (2.3) 
where WHb is gram molecule weight of haemoglobin given by 64500 g/mole[19]. 
 
Figure 2.3: Different absorbers underneath the skin tissue. The data of bilirubin is 
taken from Agati, G. and F. Fusi[20]. Absorption of melanin was reported in Meglinski 
and Matcher[15]. The absorption of deoxyhaemoglobin and oxyhaemoglobin is taken 
from Scott Prahl[19] 
Besides that, beta-carotene, glucose and water are other absorbers available 
underneath the skin. Beta-carotene is the red-orange pigment discovered in fruits and 
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